Showing results (71-80 of 527) with videos related to
Sort By:
Pageof 53
JNCI Cancer Spectrum|August 5, 2021
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance MarketYa-Chen Tina Shih, Ying Xu, Hui Zhao, et al.Cancer|May 26, 2004
Use of information resources by patients with cancer and their companionsEthan M Basch, Howard T Thaler, Weiji Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohortElena B Elkin, Arti Hurria, Nandita Mitra, et al.Gut|March 18, 2015
Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysisJennifer M Yeh, Chin Hur, Zachary Ward, et al.Clinical Colorectal Cancer|March 20, 2012
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognizedEmily Steinhagen, José G Guillem, Gerard Chang, et al.The Annals of Applied Statistics|December 9, 2022
MEASURING PERFORMANCE FOR END-OF-LIFE CARESebastien Haneuse, Deborah Schrag, Francesca Dominici, et al.Advances in Radiation Oncology|September 12, 2018
Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancerMiranda B Lam, Ling Li, Angel Cronin, et al.Medical Care|August 21, 2002
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitationsPeter B Bach, Edward Guadagnoli, Deborah Schrag, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancerJeffrey A Meyerhardt, Ling Li, Hanna K Sanoff, et al.Leukemia Research|December 3, 2014
Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS)Hajime Uno, Angel M Cronin, Martha Wadleigh, et al.Pageof 53